Caregiver Willingness to Vaccinate Children with Pneumococcal Vaccines and to Pay in a Low-Resource Setting in China: A Cross-Sectional Study

Author:

Li Linqiao,Ma YuanORCID,Li Wei,Tang Guorong,Jiang Yan,Li Huangcui,Jiang Shuxiang,Zhou Yun,Yang Yuan,Zhang Ting,Yang Weizhong,Ma Libing,Feng Luzhao

Abstract

To determine the vaccine hesitancy of pneumococcal conjugate vaccines (PCVs) in a low-resource setting in China and to identify associated factors, a face-to-face questionnaire survey was conducted in the city of Guilin, China, from December 2021 to March 2022, which comprised sociodemographic information, attitudes toward vaccines and pneumonia, and PCV13 vaccination willingness and willingness to pay (WTP). Stepwise logistic regression and Tobit regression models were fitted to identify factors associated with PCV13 vaccination willingness and WTP, respectively. In total, 1254 questionnaires were included, of which 899, 254, and 101 participants showed acceptance, hesitancy, and refusal to vaccinate their children with PCV13, respectively. Only 39.07% of participants knew about PCV13 before this survey. A total of 558 (48.40%) participants accepted the full payment of vaccination, and 477 (41.37%) other participants accepted the partial payment, with a median cost of CNY 920.00. Demographics, social and psychological context, and attitudes toward vaccines were all associated with PCV13 vaccination but varied for hesitators and refusers. There is a substantial local demand for vaccinating children with PCV13 and partial payment is widely accepted. More publicity and educational efforts and a socially supportive environment are required to alleviate vaccine hesitancy.

Funder

Education Foundation of Peking Union Medical College and Bill & Melinda Gates Foundation Donation Project

Non-profit Central Research Institute Fund of the Chinese Academy of Medical Sciences

Discipline Construction Funds of Population Medicine from Peking Union Medical College

Guilin Talent Mini-highland Scientific Research Project for COVID-19 Prevention and Control

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference40 articles.

1. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: A systematic analysis for the global burden of disease study 2017;Roth;Lancet,2018

2. Organisation mondiale de la S. pneumococcal conjugate vaccines in infants and children under 5 years of age: Who position paper—February 2019—Vaccins antipneumococciques conjugués chez les nourrissons et les enfants de moins de 5 ans: Note de synthèse de l’oms—Février 2019. Wkly. Epidemiol. Rec., 2019. 94.

3. Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia;Hanada;Front. Immunol.,2018

4. Meeting of the immunization strategic advisory group of experts, November 2007—Conclusions and recommendations. Wkly. Epidemiol. Rec., 2008. 83.

5. Direct and indirect effects of PCV13 on nasopharyngeal carriage of PCV13 unique pneumococcal serotypes in Massachusetts’ children;Loughlin;Pediatr. Inf. Dis. J.,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3